Gilead Raday, Chief Operating Officer at RedHill Biopharma, sold RDHL on Jul 10, 2026
Data as of Oct 16
▼ SELL$1.4K14,130,000 shares at $0.00Gilead Raday Chief Operating OfficerRDHL RedHill Biopharma Ltd.
- Traded
- Jul 10, 2026
- Disclosed
- Jul 13, 2026
- Filed
- 3 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
RDHL since disclosure
−30.7%
after the sale
Similar stocks (SPY) since disclosure
+1.9%
S&P 500 (SPY)
Change in closing price from Jul 13, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.